The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with ...
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...
Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM ...
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
On Friday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Datroway (datopotamab ...
CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).
As more Asia biotechs turn to regenerative medicine to address disorders without a cure, Medipost Inc. is continuing global expansion with Cartistem, its allogeneic human umbilical cord blood-derived ...
The current price of Dai (DAI) is $1.00, as of January 21, 2025. Over the last 24 hours, the price has moved by 0.05%, with a change of 0.05% in the past hour. For longer-term performance, the price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback